Compare SENEB & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SENEB | GLUE |
|---|---|---|
| Founded | 1949 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 1998 | 2021 |
| Metric | SENEB | GLUE |
|---|---|---|
| Price | $159.64 | $10.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $26.88 |
| AVG Volume (30 Days) | 267.0 | ★ 1.4M |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.85 | N/A |
| Revenue | ★ $1,314,765,000.00 | $123,672,000.00 |
| Revenue This Year | $14.06 | N/A |
| Revenue Next Year | $2.32 | N/A |
| P/E Ratio | ★ $56.01 | $72.42 |
| Revenue Growth | 4.16 | ★ 63.54 |
| 52 Week Low | $108.68 | $9.68 |
| 52 Week High | $208.53 | $25.77 |
| Indicator | SENEB | GLUE |
|---|---|---|
| Relative Strength Index (RSI) | 40.34 | 44.41 |
| Support Level | $132.23 | $9.69 |
| Resistance Level | $164.98 | $12.00 |
| Average True Range (ATR) | 0.31 | 0.56 |
| MACD | -4.84 | 0.18 |
| Stochastic Oscillator | 5.14 | 50.37 |
Seneca Foods Corp is a provider of packaged fruits and vegetables. The facilities are comprised of plants for packaging, can manufacturing, seed production, a farming operation and a logistical support network. It manages its business almost entirely on the basis of two reportable food packaging segments: Vegetable and Fruit/Snack. Majority of revenue comes from Vegetable segment. The Other category comprises non-food operations including revenue derived from the sale of cans, ends, seed, and outside revenue from the company's aircraft operations, and certain corporate items. Its principal product offerings include canned, frozen and jarred fruits and vegetables, as well as packaged snack chips. Its brands are Aunt Nellie's, Cherry man, GREEN VALLEY, Libby's, READ, and SENECA APPLE CHIPS.
Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).